Presentation TCT 2016

Atrial Fibrillation Double vs Triple Therapy Considerations and Ongoing Trials

Presenter: Pascal Vranckx

October 30, 2016

REGISTER for free or LOG IN to view this content

Atrial Fibrillation – Double vs Triple Therapy Considerations and Ongoing Trials

Clinical Cardiology

Presentation

TCT 2016

Clinical Pharma

Up Next

Presentation TCT 2016

Antiplatelet Agents: Limitations, Use Recommendations, and Investigational Agents

Presenter: David J. Moliterno

October 30, 2016

More slides +

Presentation TCT 2016

Reversal of Chronic Anticoagulation: When, What, and How Effective?

Presenter: James A. Reiffel

October 30, 2016

Presentation TCT 2016

Diabetes Advances (SGLT-2, GLP-1, DPP4)

Presenter: Norman E. Lepor

October 30, 2016

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.